Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2019 third-quarter earnings
Johnson & Johnson Q3 2019 Earnings

What you need to know about Johnson & Johnson’s 2019 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“We delivered strong revenue and earnings growth during the third quarter, while also making strategic investments that advance our innovative pipeline across all three business segments,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our colleagues around the world are passionate and committed to driving robust performance, while providing healthcare solutions that deliver long-term value to our patients, consumers, employees, communities and shareholders.”

For more details about the company’s 2019 third-quarter results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


UPDATED Johnson & Johnson Q3 2019 Earnings infographic

Johnson & Johnson’s 2019 3rd-Quarter Earnings

Read the earnings press release, which includes full financial details for the third quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.